One simple, specific, accurate, precise and reproducible and robust respectively. The % recoveries of Empagliflozin and Metformin HCl were found to be 99.60% -100.48% and 100.15% -100.23% respectively. Method was statistically validated for accuracy, precision, specificity, LOD, LOQ and robustness according to ICH guidelines.
INTRODUCTION

Empagliflozin, is chemically designated as (2S,3R,4R,5S,6R)-2-[4-chloro-3-({4-
SGLT2 co-transporters are responsible for reabsorption of glucose from the glomerular filtrate in the kidney. The glucuretic effect resulting from SGLT2 inhibition reduces renal absorption and lowers the renal threshold for glucose, therefore resulting in increased glucose excretion. Additionally, it contributes to reduced hyper glycaemia and also assists weight loss and blood pressure reduction. [1] Various analytical methods have been reported for the estimation of Empagliflozin as alone as well as in combination with other drugs. They include spectrophotometric methods [2, 3] HPLC. [4] [5] [6] Metformin Hydrochloride, is chemically designated as 1-carbamimidamido-N,Ndimethylmethanimidamide and has the molecular wt. 165.625 (figure-2). Metformin is a biguanide anti hyperglycemic agent used for treating non-insulin-dependent diabetes mellitus (NIDDM). It improves glycemic control by decreasing hepatic glucose production, decreasing glucose absorption and increasing insulin-mediated glucose uptake [7] Various analytical methods have been reported for the estimation of Metformin Hydrochloride as alone as well as in combination with other drugs. They include Titrimetric method [8] , spectrophotometric methods [9] [10] [11] , HPLC [12] [13] [14] However an extensive literature search didn't reveal any estimation method for Empagliflozin and Metfromin hydrochloride drugs in their combined dosage form. Therefore, attempt was made to stability indicating method development and Validation of simple, precise, and accurate, RP-HPLC method for simultaneous determination of Empagliflozin and Metfromin hydrochloride drugs in their combined dosage form.
MATERIALS AND METHOD
Reagents and Chemicals
Empagliflozin and Metformin hydrochloride were obtained as gift samples from Jigs Chemicals, Ahmedabad and Tuton pharma Ahmedabad respectively. HPLC grade Acetonitrile, Methanol, Water and Ortho-phosphoric acid, and Potassium Dihydrogen
Phosphate of analytical grade were obtained from Finar Chemicals Ltd.
Instruments and Chromatographic Conditions
Young lin HPLC system was used for method development and validation. Data acquisition
Forced Degradation
Forced Degradation Studies of the drugs, in combination, were performed under different stress conditions as mentioned in ICH guideline Q1A (R2). The standard solution containing 12.5μg/ml Empagliflozin and 50μg/ml Metformin HCl was subjected to acidic, alkaline and oxidative stress condition. Acidic and alkaline degradation were performed using up to 0.1 N to 2 N strength of acid/base at different temperature. Oxidative stress studies were carried out for using 3-10% H2O2.
A) Acid degradation:
The solution containing 12.5μg/ml Empagliflozin and 50μg/ml Table 4 .
B) Alkali degradation:
C) Peroxide degradation:
The solution containing 12.5μg/ml Empagliflozin and 50μg/ml Metformin HCl was subjected to different strengths of Hydrogen peroxide (H2O2) like 3%, 6% and 10%. For each strength of H2O2. Final volume was made up using the diluent. The maximum degradation was obtained with 10% H2O2 at 80°C. The representative results are shown in Table 4 .
Method Validation
1) Specificity
Specificity of method can be termed as absence of any interference at retention times of samples. Specificity was performed by injecting blank, placebo and standard preparations.
Chromatograms were recorded and retention times from sample and standard preparations were compared for identification of analytes. Specificity graph of Empagliflozin and
Metformin HCl given in figure 3-6.
2) Linearity and Range
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Metformin hCl were prepared. Plot of average peak area versus the concentration is plotted and from this the regression coefficient and regression equation were generated. The calibration data of empagliflozin and Metformin HCl is given in Table 5 and 6, while Figure   7 -9 represents linearity graphs of both drugs respectively.
3) Precision
The method was validated in terms of intra-day inter-day precision. The solution containing
12.5μg/ml of Empagliflozin and 50μg/ml of Metformin HCl was injected six times for repeatability study. Inter-day and Intra-day study was performed by injecting 10, 12.5 and 15μg/ml of Empagliflozin and 40, 50 and 60μg/ml of Metformin HCl solutions three times for each aliquots. The % RSD for precision study was found less than 2% as shown in Table   7 .
4) Accuracy
Accuracy was determined by calculating recovery of Empagliflozin and Metformin HCl by the standard addition method. Known amounts of standard solutions of Empagliflozin (6.25, 12.5 and 18.75μg/ml) and Metformin HCl (25, 50 and 75μg/mL) were added to a pre quantified test solutions of cilnidipine (3.125μg/ml) and valsartan (10μg/ml). Each solution was injected in triplicate and the recovery was calculated by measuring peak areas. Results obtained are shown in Table 8 -9.
5) LOD and LOQ
LOD and LOQ for Empagliflozin and Metformin HCl were calculated as suggested by ICH guidelines using equations LOD = 3.3 σ/s and LOQ = 10 σ/s, respectively. Where, σ is the SD of the response and S is the slope of the calibration curve.
6) Robustness
The robustness study was performed to evaluate the influence of small but deliberate variation in the chromatographic condition. The robustness was checked by making two small changes. Robustness of the method was studied by changing pH by ± 0.1, flow rate ± 0.02 mL/minutes and mobile phase composition ± 2 ml. After each changes sample solution was injected and system suitability parameters were observed. The results were shown in Table   10 .
RESULT AND DISCUSSION
System suitability study
The detection was carried out in the UV region at 227 nm. The different composition of and the system suitability parameters are shown in Table 2 .
Forced degradation study
The mentioned percent degradation of both Empagliflozin and Metformin HCl is with respect to their decrease in the areas. Peak purity of the drug is not affected.. Thus, the conditions subjected to the drugs make them undergo forced degradation thereby being able to detect any difference in the response in terms of their areas and impurities. The final results for the stress conditions are shown in Table 4 .
Method Validation
A) Specificity
The method was found to be specific as there was no interference observed in any of the parameters under observation.
B) Linearity and Range
The linearity of Empagliflozin and Metformin HCl were found between 2.5-18.75 μg/ml and 25-75 μg/ml, respectively. The results are shown in Table 5and 6.
C) Precision
The % RSD for repeatability study for Empagliflozin and Metformin HCl was found to be 0.21 and 0.32 respectively. The Inter-day and Intra-day study also show % RSD value for Empagliflozin and Metformin HCl within the acceptable limit. Results for precision study are shown in Table 7 .
D) Accuracy
Accuracy of the method was confirmed by recovery study at three levels (50%, 100% and 150%) of standard addition. Percentage recovery for Empagiflozin was found to be 99.60-100.48%, while for Metformin HCl it was found to be 100.15-100.23% as shown in Table 8 .
E) LOD and LOQ
The LOD was found to be 0.09μg/ml for Empagiflozin and 0.52μg/ml for Metformin HCl, while the LOQ was found to be 0.27μg/ml for Empagiflozin and 1.59μg/ml for Metformin
HCl.
F) Robustness
The typical variations studied under this parameter were mobile phase composition and detection wavelength. Overall % RSD was found to be less than 2% for all www.wjpps.com Vol 6, Issue 9, 2017. 878
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the variations which indicates that the proposed method is robust. Robustness data are shown in Table 9 .
G) Analysis of Physical mixture by proposed method
Applicability of the proposed method was tested by analyzing the Physical mixture. The percentage of Empagliflozin and Metformin HCl was found to be 100.16% for Empagliflozin and 99.90% for Metformin HCl. Results as % Assay are shown in Table 10 . 
